Harrow, Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Harrow, Inc. (HROW) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $111.87 thousand for the 182-month period ending 2013-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2013-11-06
- Harrow, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2013-03-31 was $0.00.
- Harrow, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2012-03-31 was $0.00.
- Harrow, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2011-12-31 was $0.00.
- Harrow, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2011-09-30 was $0.00.
- Harrow, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2012 was $0.00.
- Harrow, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2011 was $0.00.
- Harrow, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2010 was -$231.76K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 155 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 158 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 161 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 164 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 167 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 170 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 173 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 176 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 182 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $111.87K 10-Q · filed 2013-11-06 | ||||||||||||
| 2013-06-30 | $111.87K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $111.87K 10-Q · filed 2013-05-08 | |||||||||||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | $111.87K 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $111.87K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $111.87K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2013-05-08 | $0.00 derived: sum of 3 quarters · filed 2013-05-08 | $0.00 derived: sum of 4 quarters · filed 2013-05-08 | $111.87K 10-Q · filed 2012-05-10 | ||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $0.00 10-K · filed 2013-03-18 | $111.87K 10-K · filed 2012-02-23 | ||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | -$23.27K derived: sum of 4 quarters · filed 2012-05-10 | $111.87K 10-Q · filed 2012-02-23 | ||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | -$23.27K derived: sum of 3 quarters · filed 2012-05-10 | -$26.17K derived: sum of 4 quarters · filed 2012-05-10 | $111.87K 10-Q · filed 2012-02-23 | ||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | -$23.27K derived: sum of 2 quarters · filed 2012-05-10 | -$26.17K derived: sum of 3 quarters · filed 2012-05-10 | ||||||||||
| 2010-12-31 | -$23.27K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | -$26.17K derived: sum of 2 quarters · filed 2012-02-23 | -$231.76K 10-K · filed 2012-02-23 | ||||||||||
| 2010-09-30 | -$2.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23 | -$208.49K 10-Q · filed 2012-02-23 | |||||||||||
| 2010-06-30 | -$205.59K 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |